Local action, global relief

An artists representation of a neuron.

Vapogenix Inc. is an early stage company focused on developing novel, non-opioid analgesics for acute and chronic pain management. Vapogenix's licensed technology covers novel formulations of known medications through new routes of administration for new indications, with the aim of creating potent analgesic and anti-inflammatory drugs. The company’s lead product, VPX-595, is a compound being developed initially for the treatment of acute pain.

  • Vapogenix, Inc.
  • 8285 El Rio St., Suite 150
  • Houston, TX 77054
  • 713-748-3903
  • Email: info@vapogenix.com